Analyst Martin Auster works at CREDIT SUISSE and is covering the the Healthcare sector with 323 price targets and ratings documented since 2017 spanning on 26 stocks. Previously, Martin Auster worked at UBS.
Martin Auster's average stock forecast success ratio is 58.25% with an average time for price targets to be met of 181.12 days.
Most recent stock forecast was given on BMRN, BioMarin Pharmaceutical Inc at 01-Jun-2022.
Analyst best performing recommendations are on SLDB (SOLID BIOSCIENCES INC).
The best stock recommendation documented was for SLDB (SOLID BIOSCIENCES INC) at 5/14/2019. The price target of $90 was fulfilled within 1 day with a profit of $4.8 (5.06%) receiving and performance score of 50.63.
Average potential price target upside
Currently, out of the existing stock ratings of Martin Auster - 7 which are a Buy (100%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
205
$22.5 (12.33%)
2 years 1 months 1 days ago
3/5 (60%)
$36.94 (25.31%)
619
Hold
173
$-9.5 (-5.21%)
156
2 years 1 months 3 days ago
14/25 (56%)
$52.15 (41.43%)
672
Hold
190
$7.5 (4.11%)
147
2 years 1 months 11 days ago
11/13 (84.62%)
$25.6 (22.59%)
511
Buy
166
$-16.5 (-9.04%)
175
2 years 4 months 2 days ago
22/22 (100%)
$57.93 (52.29%)
755
Hold
151
2 years 4 months 29 days ago
10/10 (100%)
$48.67 (45.02%)
452
